share_log

Nikola | EFFECT: Others

SEC ·  Aug 29 18:25

Summary by Futu AI

The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated